E. Papadopoulou

ORCID: 0000-0003-2227-0127
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Herpesvirus Infections and Treatments
  • Cytomegalovirus and herpesvirus research
  • Oral and gingival health research
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Heart Failure Treatment and Management
  • Cardiovascular and exercise physiology
  • Acute Myocardial Infarction Research
  • Cardiac pacing and defibrillation studies
  • Dental Research and COVID-19
  • Cancer Diagnosis and Treatment
  • Cardiac Imaging and Diagnostics
  • HIV/AIDS oral health manifestations
  • Peripheral Neuropathies and Disorders
  • Viral Infections and Immunology Research
  • Oral Health Pathology and Treatment
  • Thyroid and Parathyroid Surgery
  • Glioma Diagnosis and Treatment
  • Dental Education, Practice, Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Osteomyelitis and Bone Disorders Research
  • Lipoproteins and Cardiovascular Health
  • Stroke Rehabilitation and Recovery
  • Adrenal and Paraganglionic Tumors
  • Salivary Gland Disorders and Functions
  • Peripheral Artery Disease Management

National and Kapodistrian University of Athens
2004-2024

Evangelismos Hospital
2024

401 General Military Hospital of Athens
2020

Alexandra Hospital
2016

Abstract Bortezomib, in combination with dexamethasone (VD) or the addition of cyclophosphamide (VCD), is highly effective patients amyloid light-chain (AL) amyloidosis. Currently, VCD considered as a primary regimen for AL, but it not clear whether to VD further and significantly improves efficacy, given substantial activity bortezomib itself. We retrospectively compared outcomes 101 AL amyloidosis who received ( n =59) =42) two consecutive periods. Early mortality after adjustment Mayo...

10.1038/bcj.2017.47 article EN cc-by Blood Cancer Journal 2017-06-16
John Kanakakis Panagiotis Stafylas Grigorios Tsigkas Dimitris Nikas Αndreas Synetos and 95 more Dimitrios Avramidis Ioannis Tsiafoutis Anna Dagre Stergios Tzikas George Latsios Nikos Patsourakos Ilias Sanidas Emmanouil Skalidis Athanasios Pipilis Panagiotis D. Bamidis Periklis Davlouros John Kanakakis M.E. Tselegkidi Eleni Sertedaki Ioannis Mamarelis E. Fraggos E. Mantzouranis Charalambos Karvounis Athanasios Manolis G. Chatzilymperis I. Chiotelis D. Gryllis Leonidas Poulimenos Andreas S. Triantafyllis Dimitrios Alexopoulos Charalampos Varlamos Georgios Almpanis A. Aggeli Andreas Sakkas Athanasios Trikas S. Tsiamis K. Triantafylloy D. Mpenia D Oikonomou E. Papadopoulou D. Avramidis Maria Kousta E. Moulianitaki G. Poulianitis G. Mavrou George Latsios Αndreas Synetos D. Tousoulis N. Kafkas Simone Godwin G. Mertzanos M. Koytouzis Ioannis Tsiafoutis A. Papadopoulos Andreas Tsoumeleas I. Barbetseas I. Sanidas Alkinoos Athanasiou Ioannis Paizis A. Kakkavas T. Papafanis Ioannis Mantas G. Neroutsos A. Gkoliopoulou V. Tafrali George F. Diakakis K. Grammatikopoulos Theodoros Sinanis Athanasios Kartalis Dimitrios Afendoulis Petros Voutas Christoforos Kardamis Alexandros Doulis N Kalantzis K. Vergis Christos Chasikidis Gerasimos S. Armatas Αναστασία Δαμέλου Maria Ntogka I. Serafetinidis K. Zagkas T. Tselempis Pantelis Makridis I. Karantoumanis E. Karapatsoudi Kostas Oikonomou Emmanouil Foukarakis P Kafarakis M Pitarokoilis E. Rogdakis Stavros Stavrakis G. Koudounis V. Karampetsos Nikolaos Lionakis Charalampos Panotopoulos D. Svoronos Ioannis Tsorlalis Konstantinos Tsatiris Eirini Beneki Nikolaos G. Papadopoulos

Acute myocardial infarction (AMI) is one of the leading causes death; however, updated data regarding clinical presentation and current management are missing in Greece. This study aimed to prospectively record demographic characteristics a representative sample patients suffering from AMI, their management, short-term outcomes.ILIAKTIS national, prospective, multicenter, noninterventional conducted under auspices Hellenic Society Cardiology (HCS) European Initiative Stent - Save Life. From...

10.1016/j.hjc.2022.03.003 article EN cc-by-nc-nd Hellenic Journal of Cardiology 2022-03-17

Abstract Introduction Patients with chronic heart failure (CHF) have been presented microcirculation alterations and vascular endothelial dysfunction. Exercise training programs, including inspiratory muscle (IMT) as an alternative/additional means of exercise, shown to improve the functional status these patients. However, there has not much data on acute effect IMT systemic microcirculation. Purpose The aim this study was investigate session non-exercising muscles (systemic effect) in CHF...

10.1093/eurjpc/zwae175.158 article EN other-oa European Journal of Preventive Cardiology 2024-06-01

Abstract Introduction Chronic heart failure (CHF) has been characterized with microcirculation and endothelial abnormalities, as well impaired function of the respiratory system. Exercise training programs have an important component CHF rehabilitation. Inspiratory muscle (IMT), a supplementary form exercise, induces beneficial effects on functional status patients; however, there not much data its systemic microcirculation. Purpose The aim study was to evaluate effect addition IMT regime...

10.1093/eurjpc/zwae175.162 article EN other-oa European Journal of Preventive Cardiology 2024-06-01

Background/Objectives: The etiology of diffuse gingival enlargement is multifactorial, and the definitive diagnosis may be challenging. To highlight nuances differential diagnosis, we present two cases generalized overgrowth discuss diagnostic dilemmas. Case description: In first case, an 82-year-old male with a medical history hypertension prostatitis had chief complaint symptomatic oral lesions 20-day duration, accompanied by fever loss appetite. clinical examination revealed diffusely...

10.3390/dj12120403 article EN cc-by Dentistry Journal 2024-12-10

Background: Burkitt lymphoma (BL) is an aggressive non-Hodgkin (NHL), subdivided into endemic, sporadic, and immunodeficiency-associated forms. While jaw lesions are common in endemic BL, they infrequent sporadic cases, only rarely constituting the first manifestation of disease. The aim this study to present a rare pediatric case BL manifesting as gingival swellings tooth hypermobility provide review all published reports sign Case report: An 11-year-old Caucasian female was referred for...

10.3390/dj13010006 article EN cc-by Dentistry Journal 2024-12-25

Panitumumab is an anti-epithelial growth factor receptor monoclonal antibody, approved for the treatment of metastatic colorectal cancer. has been more commonly associated with skin toxicity; oral adverse events have scarcely reported in literature. Herein, we present a case report panitumumab-associated aphthous-like stomatitis. A 58 years old female visited Oral Oncology Unit complaining severe pain. The patient had diagnosed colon cancer to liver and was receiving panitumumab (every 14...

10.5037/jomr.2024.15405 article EN cc-by-nc-nd Journal of Oral and Maxillofacial Research 2024-12-31

The symptoms of herpes simplex viruses type 1 (HSV-1) infections might be severe and persistent in immunocompromised patients whom they reactivate at a high frequency. development Acyclovir (ACV) resistant strains due to long-term treatment with antiviral agents those is not uncommon. aim the present study was assess virucidal effect commercially available mouthwashes against ACV-resistant HSV-1 strains.

10.1111/odi.14843 article EN Oral Diseases 2023-12-27
John Kanakakis Panagiotis Stafylas Dimitrios Avramidis Anna Dagre George Latsios and 95 more Dimitris J. Nikas Nikos Patsourakos Athanasios Pipilis Ilias Sanidas Emmanouil Skalidis Αndreas Synetos Dimitrios Tziakas Stergios Tzikas Ioannis Tsiafoutis Grigoris Tsigkas Panagiotis D. Bamidis John Kanakakis M.E. Tselegkidi Eleni Sertedaki I. marelis E. Fragkos E. Mantzouranis Charalambos Karvounis Stefanos Zafeiropoulos Athanasios Manolis G. Chatzilymperis I. Chiotelis D. Gryllis Leonidas Poulimenos Andreas S. Triantafyllis Dimitrios Alexopoulos Charalampos Varlamos Georgios Almpanis A. Aggeli Andreas Sakkas Athanasios Trikas S. Tsiamis K. Triantafylloy D. Mpenia D Oikonomou E. Papadopoulou D. Avramidis Maria Kousta E. Moulianitaki G. Poulianitis G. Mavrou George Latsios Αndreas Synetos D. Tousoulis N. Kafkas Simone Godwin G. Mertzanos M. Koytouzis Ioannis Tsiafoutis A. Papadopoulos Andreas Tsoumeleas I. Barbetseas I. Sanidas Alkinoos Athanasiou Ioannis Paizis A. Kakkavas T. Papafanis Ioannis Mantas G. Neroutsos A. Gkoliopoulou V. Tafrali N. Florou George F. Diakakis K. Grammatikopoulos Theodoros Sinanis Athanasios Kartalis Dimitrios Afendoulis Petros Voutas Christoforos Kardamis Alexandros Doulis N Kalantzis K. Vergis Christos Chasikidis Gerasimos S. Armatas Αναστασία Δαμέλου Maria Ntogka I. Serafetinidis K. Zagkas T. Tselempis Pantelis Makridis I. Karantoumanis E. Karapatsoudi Kostas Oikonomou Emmanouil Foukarakis P Kafarakis M Pitarokoilis E. Rogdakis Stavros Stavrakis G. Koudounis V. Karampetsos Nikolaos Lionakis Charalampos Panotopoulos D. Svoronos Ioannis Tsorlalis Konstantinos Tsatiris

10.1016/j.hjc.2020.06.011 article EN cc-by-nc-nd Hellenic Journal of Cardiology 2020-07-14

We report the case of a 63-year-old patient with myasthenia gravis (MG) due to acetylcholine receptor antibodies (AChR) who underwent colectomy colon adenoma and developed myasthenic crisis anastomosis leakage after surgery. The two plasma exchanges, 4 6 days preoperatively, received intravenous prednisolone immunoglobulin infusion crisis, which included primarily bulbar symptoms. on 10th postoperative day bowel obstruction symptoms required surgical repair ileostomy. Bowel occurred in AChR...

10.1155/2016/6297656 article EN cc-by Case Reports in Neurological Medicine 2016-01-01

Background: Bortezomib/dexamethasone with cyclophosphamide or melphalan are commonly used as primary treatment for AL amyloidosis, but limited data exist on the safety and activity of bortezomib IMiDs combinations. Aims: To evaluate VRD combination in newly diagnosed, previously untreated patients amyloidosis. Methods: Between March 2017 2018, 34 consecutive diagnosed amyloidosis were treated VRD; standard organ involvement updated hematologic response criteria used. Results: The median age...

10.1097/01.hs9.0000563848.50917.67 article EN cc-by-nc-nd HemaSphere 2019-06-01
Coming Soon ...